![A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya) - Jerold Chun - Discovery Medicine A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya) - Jerold Chun - Discovery Medicine](https://www.discoverymedicine.com/Jerold-Chun/files/2011/09/discovery_medicine_no_64_volker_brinkmann_figure_1.png)
A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya) - Jerold Chun - Discovery Medicine
![Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action - The Lancet Neurology Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2000998078/2003706148/gr1.jpg)
Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action - The Lancet Neurology
![IJMS | Free Full-Text | What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis? IJMS | Free Full-Text | What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?](https://www.mdpi.com/ijms/ijms-13-12665/article_deploy/html/images/ijms-13-12665f3.png)
IJMS | Free Full-Text | What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?
![Frontiers | Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis | Neurology Frontiers | Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis | Neurology](https://www.frontiersin.org/files/Articles/415264/fneur-09-00973-HTML/image_m/fneur-09-00973-g001.jpg)
Frontiers | Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis | Neurology
![New Research Points the Way Towards Mechanism of Action, Receptor for MS Copolymer Drugs – Sanguine Bio Researcher Blog New Research Points the Way Towards Mechanism of Action, Receptor for MS Copolymer Drugs – Sanguine Bio Researcher Blog](https://technical.sanguinebio.com/wp-content/uploads/2013/07/Multiple_sclerosis_T_cells.jpg)
New Research Points the Way Towards Mechanism of Action, Receptor for MS Copolymer Drugs – Sanguine Bio Researcher Blog
![Current immunotherapies for multiple sclerosis and neuromyelitis optica spectrum disorders: the similarities and differences Current immunotherapies for multiple sclerosis and neuromyelitis optica spectrum disorders: the similarities and differences](https://oaepublishstorage.blob.core.windows.net/f8404a55-4f2e-43a8-a8a8-282d613ab193/3077.fig.1.jpg)
Current immunotherapies for multiple sclerosis and neuromyelitis optica spectrum disorders: the similarities and differences
![Mechanisms of mitoxantrone in multiple sclerosis–what is known? - Journal of the Neurological Sciences Mechanisms of mitoxantrone in multiple sclerosis–what is known? - Journal of the Neurological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2001316031/2005073025/gr1.jpg)
Mechanisms of mitoxantrone in multiple sclerosis–what is known? - Journal of the Neurological Sciences
![Proposed mechanism of MS pathogenesis. MΦ, macrophage; EC, Endothelial... | Download Scientific Diagram Proposed mechanism of MS pathogenesis. MΦ, macrophage; EC, Endothelial... | Download Scientific Diagram](https://www.researchgate.net/profile/Mouzaki-Athanasia/publication/7583209/figure/fig1/AS:601672392921108@1520461285602/Fig-1-Proposed-mechanism-of-MS-pathogenesis-MPH-macrophage-EC-Endothelial-Cell-T.png)
Proposed mechanism of MS pathogenesis. MΦ, macrophage; EC, Endothelial... | Download Scientific Diagram
![Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines | PNAS Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines | PNAS](https://www.pnas.org/content/pnas/101/suppl_2/14599/F2.large.jpg)
Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines | PNAS
![Role of CNS-specific “autoregulatory” CD8 T-cells in autoimmune demyelinating disease | Nitin Karandikar Laboratory—Department of Pathology Role of CNS-specific “autoregulatory” CD8 T-cells in autoimmune demyelinating disease | Nitin Karandikar Laboratory—Department of Pathology](https://karandikar.lab.uiowa.edu/sites/karandikar.lab.uiowa.edu/files/wysiwyg_uploads/cd8-mechanism.jpg)